Cerenome, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-22.4M | $-13.0M | $-13.3M | $-20.3M | $-13.4M | $-8.2M | $-10.9M | $-12.6M |
| Depreciation & Amortization | $445.0K | $872.0K | $628.0K | $619.0K | $395.0K | $366.0K | $896.0K | $2.0M |
| Depreciation | $200.0K | $600.0K | $600.0K | $500.0K | $400.0K | $400.0K | $900.0K | $300.0K |
| Amortization | $100.0K | $100.0K | $100.0K | $100.0K | $32.0K | — | — | $1.3M |
| Stock-Based Compensation | $1.5M | $550.0K | $569.0K | $606.0K | $606.0K | $247.0K | $127.0K | $355.0K |
| Net Cash from Operating Activities | $-20.8M | $-10.6M | $-12.9M | $-13.0M | $-10.3M | $-8.4M | $-5.9M | $-12.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $67.0K | $146.0K | $160.0K | — | — | — | $67.0K | $133.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-854.0K | $-4.1M | $-160.0K | $-759.0K | $-82.0K | $-493.0K | $5.6M | $-133.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $30.3M | $6.2M | $3.4M | $13.5M | $20.4M | $-319.0K | $12.6M | $7.2M |
| Net Change in Cash | $8.7M | $-8.5M | $-9.6M | $-280.0K | $10.1M | $-9.2M | $12.3M | $-4.9M |
| Free Cash Flow | $-20.8M | $-10.7M | $-13.0M | — | — | — | $-6.0M | $-12.1M |